Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
Not Confirmed
Not Confirmed
19-22 May, 2025
Not Confirmed
Not Confirmed
20-22 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
Industry Trade Show
Not Confirmed
19-22 May, 2025
Industry Trade Show
Not Confirmed
20-22 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
06 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-presents-preclinical-results-of-cs2011-egfrher3-bispecific-antibody-cs5007-egfrher3-bispecific-adc-cs5005-sstr2-adc-and-cs5006-itgb4-adc-at-2025-aacr-302447053.html
05 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-presents-the-latest-preclinical-findings-of-cs2009-pd-1vegfctla-4-trispecific-antibody-at-2025-aacr-302446074.html
27 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-pharmaceuticals-announces-2024-annual-results-and-recent-business-progress-302413130.html
25 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-to-showcase-five-latest-research-achievements-at-aacr-2025-302407851.html
23 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-submits-application-to-the-european-medicines-agency-for-new-indication-of-sugemalimab-in-stage-iii-non-small-cell-lung-cancer-302408587.html
05 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-submits-clinical-trial-application-in-australia-for-cs5001-ror1-adc-in-combination-with-first-line-standard-of-care-for-dlbcl-302393846.html
ABOUT THIS PAGE